Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells

A. Boots (Maastricht, Netherlands), C. Veith (Maastricht, Netherlands), M. Kreuter (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), M. Meister (Heidelberg, Germany), A. Smolinska (Maastricht, Netherlands), F. Van Schooten (Maastricht, Netherlands), N. Kahn (Heidelberg, Germany)

Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Session: Cellular stress in respiratory diseases
Session type: E-poster session
Number: 605
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Boots (Maastricht, Netherlands), C. Veith (Maastricht, Netherlands), M. Kreuter (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), M. Meister (Heidelberg, Germany), A. Smolinska (Maastricht, Netherlands), F. Van Schooten (Maastricht, Netherlands), N. Kahn (Heidelberg, Germany). Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells. 605

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001

The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


Characterization of in vitro differentiated bronchial epithelial cells obtained from patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 99s
Year: 2004

Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Apoptosis in epithelial cells in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004

Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia
Source: Eur Respir J 2003; 22: Suppl. 45, 416s
Year: 2003

Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020


Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004

Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care
Source: Eur Respir J 2008; 32: 945-952
Year: 2008



Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016